Taxane rechallenge during metastatic disease in HER-2 negative breast cancer patients: Clinical activity, tolerance and survival results
暂无分享,去创建一个
A. Bertaut | S. Ladoire | C. Kaderbhai | I. Desmoulins | B. Coudert | D. Mayeur | S. Ilie | A. Hennequin | M. Réda | A. Fouquier